Chronic Osteomyelitis / Bone Infection Flap Reconstruction | Confirming bone infection and its extent

Exposed or palpable bone at first evaluation is treated as osteomyelitis until proven otherwise. Bone biopsy is the gold standard. If the patient lacks sensation, obtain it during initial evaluation with a rongeur; debride overlying bone exposed to the environment and take a deep, clean bone biopsy with a clean rongeur. MRI has 80% to 100% sensitivity and 70% to 100% specificity and can determine disease extent. Bone scans are not specific but can rule out osteomyelitis if negative. This matters because chronic osteomyelitis involves infected bone and scarred surrounding tissue with diminished blood supply, so treatment requires debridement to viable noninfected bone, vascularized flap coverage and culture-specific antibiotics.

Chronic osteomyelitis is a long-standing bone infection, often after open fracture or orthopedic treatment. It may show bone changes on imaging or persistent sinus tracts after adequate antimicrobial therapy and surgical debridement. An elevated erythrocyte sedimentation rate is suggestive and warrants work-up with bone biopsy, but blood tests are not definitive. Bone biopsy remains the gold standard. Active osteomyelitis is a relative contraindication to flap reconstruction, so confirming or excluding infection matters before reconstructive planning. It can wax and wane, sometimes suppressed for long periods with local wound care and supplemental antibiotics, yet still require radical debridement and well-vascularized coverage. Not all cases can be salvaged; amputation may be discussed when nerves are too damaged.

Conventional X-rays usually come first because they give an overview of bone and soft-tissue anatomy and may show subtle signs such as loss of trabecular markings, periosteal elevation, cortical scalloping, medullary involvement or focal osteopenia. CT can detect early bone erosion and document dead bone fragments, foreign bodies or gas; it is also useful for spinal lesions and surgical planning. MRI is the most useful for suspected osteomyelitis: it detects changes early, shows marrow and soft-tissue involvement, and helps define dead tissue and nearby structures. MRI can also reveal fluid under the bone covering or a chronic bone abscess, while CT may show dead bone with surrounding new bone.

Chronic osteomyelitis involves infected dead bone in a compromised soft-tissue envelope, so systemic antibiotics are relatively ineffective. Sinus-tract samples may grow different bacteria than bone biopsy. Antibiotics penetrate poorly into devitalised bone, so defining the infecting organism from the outset helps target treatment. Ideally, without systemic illness, microbiological sampling of infected bone should precede antibiotic therapy. Guidelines for diabetic foot, vertebral, paediatric osteomyelitis and prosthetic joint infections recommend withholding antibiotics unless there is acute need such as sepsis, cellulitis, deep abscess or ascending infection. Antimicrobial therapy is then individualised by culture and response. Surgery can debride necrotic bone and provide deep samples; when surgery is not possible, prolonged antibiotics may be warranted.

In chronic osteomyelitis, prior antibiotics may suppress but not fully eradicate organisms in retained bone, scar, or biofilm. A negative culture therefore does not always exclude residual infection, while a positive culture after treatment suggests persistent organisms. Post-debridement cultures help assess debridement quality: if no growth is seen, a shorter antibiotic course is often sufficient, while a positive culture may prompt re-resection or a longer course. Even without clinical signs or elevated inflammatory markers, some patients remain culture positive at bone grafting. In flap reconstruction, positive wound-bed cultures predict more complications, and effective antibiotics against the organisms that grow can lower that risk. Antibiotic choice and duration are best guided by an infectious disease specialist.

In chronic osteomyelitis, infection can block blood supply to bone, leaving dead bone surrounded by hardened, poorly supplied bone and scarred soft tissue. This makes antibiotics less effective, and bacteria from draining sinuses may differ from those found in bone samples. Treatment centers on removing dead bone, controlling infection, and covering the area with healthy, well-supplied tissue. The dead bone can keep infection alive because it is avascular and difficult for medicines to reach. Surgery is often needed to remove it, while antibiotics help control surrounding infection. Recovery depends on how much bone and soft tissue are involved, and on overall health. Not every case can be saved, and amputation may be discussed in severe situations.

Chronic hardware exposures are arbitrarily defined as exposure more than six months after placement, and long-term coverage of chronically exposed hardware is not successful. Infection is likely when small drainage allows palpation of hardware, or when fluid collections or cysts occur with hardware; these infections may persist for months or years with low-virulence organisms such as Staphylococcus epidermidis. A retained orthopedic fixation device reduces the likelihood of bacterial eradication. Removing devitalized bone or involved prosthetic plates, closing with vitalized tissue, and using long-term antibiotic therapy may control infection. Hardware involved in infection is not removed until clinical union is demonstrated, which may take six weeks or more.

In chronic osteomyelitis, secondary infections are common, and sinus-tract cultures usually do not match cultures from bone biopsy. Multiple organisms may grow from sinus tracts and from open biopsy specimens of surrounding soft tissue and bone. Bone biopsy is the gold standard for diagnosing osteomyelitis, and an elevated ESR is suggestive enough to warrant work-up with bone biopsy. Chronic inflammation can also mimic conditions such as lupus, sarcoidosis, Wegener's granulomatosis or tuberculosis, so biopsy may help distinguish them. A draining tract alone is not enough to decide the exact disease or treatment plan. Because sinus-tract cultures may mislead, bone biopsy remains important when diagnosis is uncertain and it can guide targeted treatment.

Chronic osteomyelitis treatment centers on complete debridement, filling dead space and covering the defect with well-vascularized tissue, often with a brief antibiotic course. Diabetes adds concerns such as chronic bacterial colonization, complex wounds, bone deformity, local wound ischemia and vascular disease, so patients are best managed by a multidisciplinary team. Before reconstructive surgery, vascular status must be evaluated, and any vascular problem addressed first. Blood flow may need optimization, including revascularization for larger vessels or hyperbaric oxygen for smaller ischemic vessels. With good glycemic control, flap and donor-site complication rates do not differ significantly between type 1 or type 2 diabetes and no diabetes, although poor long-term control with HbA1c above 6.5% increases wound dehiscence.